- $3.14bn
- $3.06bn
- $125.81m
- 24
- 10
- 43
- 14
Annual balance sheet for HeartFlow, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Cash and Short Term Investments | 123 | 51.4 |
| Net Total Accounts Receivable | ||
| Net Total Receivables | 20.5 | 24.6 |
| Prepaid Expenses | ||
| Total Other Current Assets | ||
| Total Current Assets | 148 | 82.3 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 30.9 | 27.7 |
| Other Long Term Assets | ||
| Total Assets | 185 | 119 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Total Current Liabilities | 32.8 | 33.6 |
| Long Term Debt | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 194 | 210 |
| Redeemable Preferred Stock | ||
| Non Redeemable Preferred Stock | ||
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Other Equity | ||
| Total Equity | -9 | -90.9 |
| Total Liabilities & Shareholders' Equity | 185 | 119 |
| Total Common Shares Outstanding |